reports
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
AVAV AEROVIRONMENT INC.
KFS KINGSWAY FINANCIAL SERVICES
PAYS PAYSIGN INC
PRCH PORCH GROUP INC (A)
SPNT SIRIUSPOINT LTD
MSGE MADISON SQUARE GARDEN ENTERTAINMENT
OSCR OSCAR HEALTH
JOBY JOBY AVIATION INC
COIN COINBASE GLOBAL INC
EVEX EVE HOLDING INC
GCT GIGACLOUD TECHNOLOGY INC
CRBG COREBRIDGE FINANCIAL INC.
SGHC SUPER GROUP (SGHC) LIMITED
RDW REDWIRE CORP
DAVE DAVE INC
GRALV GRAIL INC.
SMCI SUPER MICRO COMPUTER INC.
EVTL VERTICAL AEROSPACE LTD.
ANET ARISTA NETWORKS INC
OWLT OWLET INC
ESP BROMPTON ENERGY SPLIT CORP
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Receive...
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis Trial will be conducted by Angel Pharma and will study 12-week dosing of soquelitinib in patients with moderate-to-severe atopic dermatitis SOUTH SAN FRANCISCO, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the IND application submitted by its partner in China, Angel Pharmaceuticals Ltd. (Angel Pharma), h...
TMC Announces Appointment of Michael Hess and Alex Spiro to its Board ...
TMC Announces Appointment of Michael Hess and Alex Spiro to its Board of Directors Michael Hess, an experienced investor and operator in the energy sector, brings deep networks and expertise in financing and developing businesses focused on the U.S. energy supply chainAlex Spiro, a high-profile U.S. attorney and investor, joins with extensive regulatory, governance and capital markets experience across sectors including energy, technology, and miningAppointments strengthen TMC’s Board as the Company executes on its U.S. strategy and accelerates progress toward commercial recovery of polymet...
TMC Announces Strategic Investment from Korea Zinc — a World-Leader in...
TMC Announces Strategic Investment from Korea Zinc — a World-Leader in Non-Ferrous Metal Refining and pCAM Technology — to Advance Development of Deep-Seabed Critical Minerals in the U.S. Korea Zinc Co., Ltd., (Korea Zinc) will make a strategic equity investment in TMC of $85.2 million in exchange for 19.6 million common shares at the last market closing price of $4.34 per shareInvestment includes a three-year warrant to purchase 6.9 million common shares (0.35 warrant shares for every 1 initial common share) with an exercise price of $7.00 per share, and a participation right to subscribe ...
Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data Highligh...
Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data Highlighting Potential of ITK inhibition to Treat Systemic Sclerosis at EULAR 2025 Congress SOUTH SAN FRANCISCO, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced preclinical data highlighting the potential of soquelitinib to treat systemic sclerosis will be presented today in a poster session at the European Alliance of Associations for Rheumatology (EULAR) 2025 Congress, which is taking place June 11-14, 2025 in Barcelona. The pos...
TMC and Nauru Announce Updated Sponsorship Agreement for Nauru Ocean R...
TMC and Nauru Announce Updated Sponsorship Agreement for Nauru Ocean Resources Inc. (NORI) The Government of Nauru and TMC’s subsidiary, Nauru Ocean Resources Inc. (NORI), signed a revised Sponsorship Agreement updating the terms of their agreement signed in 2017The President of Nauru welcomes the new agreement which will ensure that Nauruans will receive benefits from any future development of seafloor mineral resources from NORIThe Republic of Nauru has played a leading role in the development of the seafloor minerals industry, advancing the rights of Developing States to ensure their par...
Corvus Pharmaceuticals Announces Full Data from Cohort 3 of Placebo-Co...
Corvus Pharmaceuticals Announces Full Data from Cohort 3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis Cohort 3 demonstrates earlier and deeper responses compared to cohorts 1-2 All three cohorts show separation from placebo with statistically significant difference from placebo at day 28 Cohort 3 demonstrates clinically meaningful reduction in itch as early as day 8 Enrollment initiated in extension cohort study exploring the same cohort 3 dose (200 mg BID) for a longer 8-week treatment period SOUTH SAN FRANCISCO, Calif., June 04, 2025 (GLOBE N...
Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthc...
Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference SOUTH SAN FRANCISCO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one-on-one meetings with investors and present a corporate overview at the 2025 Jefferies Global Healthcare Conference, which is being held in New York, NY. The presentation will be on Thursday, June 5 from 9:20-9:50 am ET. A webcast of the presentation will be available live and for 90 days ...
Creative Realities to Participate in Ladenburg Thalmann Innovation Exp...
Creative Realities to Participate in Ladenburg Thalmann Innovation Expo LOUISVILLE, Ky., May 15, 2025 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions, today announced that it will participate in the Ladenburg Thalmann Innovation Expo 2025, at Convene, 101 Park Avenue, New York on Wednesday May 21. One-on-one meetings will be available for institutional investors, and a general presentation will be held at 1pm Eastern. To schedule a meeting with CRI, contact Ladenb...
TMC Provides First Quarter 2025 Corporate Update
TMC Provides First Quarter 2025 Corporate Update NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or “the Company”), a leading explorer of the world’s largest undeveloped resource of critical metals essential to energy, defense, manufacturing, and infrastructure, today provided a corporate update and first quarter results for the period ending March 31, 2025. Q1 2025 Financial Highlights Total liquidity of approximately $43.8 million at March 31, 2025, including cash of $2.3 million ERAS/Barron facility increased from $38 million to $44 million...
Creative Realities Reports Fiscal 2025 First Quarter Results
Creative Realities Reports Fiscal 2025 First Quarter Results With New Wins on Hand, Company Remains Positioned for Record Year of Performance LOUISVILLE, Ky., May 14, 2025 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions, today announced its financial results for the fiscal first quarter ended March 31, 2025. Highlights: First quarter revenue of $9.7 million versus $12.3 million in the prior-year periodGross profit of $4.5 million for the three months ended Mar...
TMC Announces $37 Million Strategic Investment to Advance Deep-Sea Min...
TMC Announces $37 Million Strategic Investment to Advance Deep-Sea Mineral Development The financing is led by Michael Hess, Chief Investment Officer of Hess Capital, and Brian Paes-Braga, Managing Partner at SAF Group and Head of SAF GrowthIt comprises a Registered Direct Offering at $3.00 per share and warrants exercisable at $4.50 per share, with mandatory exercise if shares trade above $7.00 per share for 20 consecutive daysProceeds are expected to be sufficient to fund operations through the potential issuance of a commercial recovery permitThe investor group brings decades of experien...
Corvus Pharmaceuticals Provides Business Update and Reports First Quar...
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2025 Financial Results Soquelitinib data from cohorts 1-3 of atopic dermatitis Phase 1 clinical trial demonstrate favorable safety and efficacy profile, including earlier and deeper responses in cohort 3 compared to cohorts 1-2 Phase 3 registrational clinical trial of soquelitinib in peripheral T cell lymphoma (PTCL) enrolling with multiple clinical sites open Early exercise of common stock warrants by stockholders providing cash proceeds of approximately $31.3 million Soquelitinib data to be highlighted on confere...
Corvus Pharmaceuticals Announces Data from Cohorts 1-3 of Placebo-Cont...
Corvus Pharmaceuticals Announces Data from Cohorts 1-3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis Data continue to demonstrate favorable safety and efficacy profile, including earlier and deeper responses in cohort 3 compared to cohorts 1-2 Data to be presented in an oral session and poster at the Society for Investigative Dermatology 2025 Annual Meeting Company to discuss data today on its first quarter 2025 business update conference call and webcast at 4:30 pm ET / 1:30 pm PT SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Corvus...
The Metals Company Announces First Quarter 2025 Corporate Update Confe...
The Metals Company Announces First Quarter 2025 Corporate Update Conference Call for Wednesday, May 14, 2025 NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or the “Company”), an explorer of the world’s largest undeveloped resource of critical metals for energy, defense, manufacturing and infrastructure, today announced that it will host a conference call on Wednesday, May 14, 2025, to provide an update on first quarter 2025 financial results and recent corporate developments. First Quarter 2025 Conference Call Details Date:Wednesday, May 14...
TMC CEO Testifies Before Congress: Deep-Sea Minerals Key to U.S. Indus...
TMC CEO Testifies Before Congress: Deep-Sea Minerals Key to U.S. Industrial Future CEO and Chairman Gerard Barron testified before the House Committee on Natural Resources on “Exploring the Potential of Deep-Sea Mining to Expand American Mineral Production”Mr. Barron highlighted the abundant, unattached polymetallic nodule resource as a platform to secure new supplies of critical minerals essential for U.S. infrastructure, defense, energy, and technology—and to drive reindustrialization across shipbuilding, port infrastructure, minerals processing, and manufacturingTMC USA that it submitte...
Creative Realities, Inc. Announces First Quarter 2025 Earnings Release...
Creative Realities, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call Information LOUISVILLE, Ky., May 05, 2025 (GLOBE NEWSWIRE) -- ("Creative Realities," "CRI," or the "Company") (NASDAQ: ), a leading provider of digital signage and media solutions, announced today that it will release its financial results for the three months ended March 31, 2025 before the market open on Wednesday, May 14, 2025. A conference call to review the results is scheduled for Wednesday, May 14, 2025, at 9:00 am Eastern Time, which will include prepared remarks and materials from man...
World First: TMC USA Submits Application for Commercial Recovery of De...
World First: TMC USA Submits Application for Commercial Recovery of Deep-Sea Minerals in the High Seas Under U.S. Seabed Mining Code Following last week’s , ‘Unleashing America’s Offshore Critical Minerals and Resources’, TMC USA has submitted applications to the National Oceanic and Atmospheric Administration (NOAA) for two exploration licenses and one commercial recovery permit under the Deep Seabed Hard Mineral Resources Act (DSHMRA)The commercial recovery permit application advances TMC’s timeline ahead of its original June 27 application target, further strengthening the Company’s lead...
TMC Welcomes U.S. Executive Order to Expedite Permitting and Evaluate ...
TMC Welcomes U.S. Executive Order to Expedite Permitting and Evaluate Offtake of Critical Minerals from Nodules in the High Seas Entitled ‘Unleashing America’s Offshore Critical Minerals and Resources’, the Executive Order directs Commerce Secretary Lutnick to expedite deep seabed mineral exploration licenses and commercial recovery permits in international waters under the existing U.S. seabed mining codeThe Order also directs the Secretaries of Defense and Energy to address the feasibility of using the National Defense Stockpile for nodule-derived minerals and of entering into offtake agr...
Corvus Pharmaceuticals to Present New Interim Data from Placebo-Contro...
Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025 Data from Cohorts 1-3 of trial to be presented in an oral session and poster at the Society for Investigative Dermatology (SID) 2025 Annual Meeting Company to discuss data on its first quarter 2025 business update conference call and webcast scheduled for 4:30 pm ET / 1:30 pm PT on May 8, 2025 SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical com...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.